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SumlTlary 
The opacity (Opa) proteins of Neisseria gonorrhoeae  are a family of outer membrane proteins 
demonstrating phase and antigenic variation. IV. gonorrhoeae  strain FA0190 has 11 opa loci that 
encode at least 8 antigenically distinct Opa proteins. To determine if expression of one Opa protein 
or a subset of them is favored during gonococcal infection, we inoculated Opa-negative variants 
of strain FA1090 intraurethrally into male volunteers. The Opa phenotype of gonococci isolated 
from urine and urethral swab cultures from nine infected subjects was determined. Opa proteins 
were expressed in a large proportion of the reisolates from the infected subjects. Gonococci cultured 
from urine or urethral swab samples from six of the subjects were uniformly Opa positive, with 
the predominant Opa  variants  differing among subjects.  Three different Opa proteins were 
represented as the predominant type in at least  one subject each. In three subjects,  there was 
more heterogeneity in Opa phenotype of the reisolates,  including the presence of Opa-negative 
variants. An increase in the proportion of isolates  expressing multiple Opa proteins occurred 
over time in most subjects.  Passage of the inoculum in vitro did not result in similar changes 
in Opa expression. There was no detectable difference in infectivity of an Opa-negative variant 
and one expressing an Opa protein (OpaF) that was highly represented in reisolates from the 
original nine subjects. Reisolates from three infected volunteers inoculated with the OpaF variant 
showed continued expression of OpaF alone or in conjunction with other Opa proteins. These 
results demonstrate that there is strong selection for expression of one or more Opa proteins 
by strain FA1090 in vivo, but that no single protein is preferentially expressed during early infection 
in the male urethra. 
isseria gonorrhoeae is the causative agent of the sexually 
ransmitted disease gonorrhea. Humans are the exclu- 
sive host of N. gonorrhoeae;  although some animal models 
have been described, their usefulness in studying pathogen- 
esis has been limited by their lack of similarity to human 
mucosal disease (1). N. gonorrhoeae  infection of men, unlike 
that of women, rarely leads  to complications (2),  and ex- 
perimental infection of adult men has been used to study poten- 
tial virulence factors and to evaluate candidate vaccines (3-8). 
The  gonococcus has  a  number  of surface components 
demonstrating phase and antigenic variation.  Reversible, high- 
frequency switches in expression result in turning on or off 
the synthesis of a component (phase variation) or in changing 
from one expressed antigenic version of a component to an- 
other (antigenic variation). These variable components in- 
clude the opacity (Opa) 1 proteins of the outer membrane 
1 Abbreviations used in this paper: ECL, enhanced  chemiluminescence;  FSM, 
freezer  storage  medium;  HV, hypervariable;  LOS, lip0oligosaccharide;  Opa, 
opacity. 
(previously designated Protein  II).  Opa  proteins  are heat 
modifiable and range from 25 to 30 kD in molecular mass. 
Gonococci can express  a number of antigenically different 
Opa proteins; a single bacterium can express none of the pro- 
teins,  one protein, or multiple Opa proteins. Expression of 
different Opa proteins affects the photo-opacity of gonococcal 
colonies, with Opa variants of a strain ranging from trans- 
parent to deeply opaque in colony phenotype (reviewed in 
reference 9). 
Individual Opa proteins are encoded by separate structural 
genes. Each gene oscillates  between expression and nonex- 
pression at an in vitro rate of ~o103/cell per generation by 
a frameshifting mechanism involving insertions or deletions 
of copies of a repetitive DNA sequence (10-13).  Because of 
this high rate of variation, gonococcal populations cultured 
in the laboratory consist of mixtures of different Opa vari- 
ants.  The olva genes contain both  conserved and variable 
regions, including two hypervariable (HV) regions encoding 
structurally and antigenically variable portions of the pro- 
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quence repertoires are not the same in all gonococcal strains, 
although some HV regions are present in multiple strains 
(14, 15,  17). 
Opa proteins are expressed in vivo,  and variation in Opa 
expression  occurs  during both  natural  and  experimental 
gonococcal infection (6, 18, 19). Altering the expression and 
antigenic type of these immunodominant surface components 
may aid the organisms in evading the host immune response. 
In addition, different Opa proteins may have different func- 
tions. This latter view has emerged from recent studies on 
the ability of Opa proteins to mediate adherence to and inva- 
sion of different host cell types in vitro, including epithelial 
cells and neutrophils (20-24).  These studies have led to the 
suggestion that the expression of different Opa proteins may 
influence tissue tropism in vivo, so that particular Opa pro- 
teins may be important in the establishment or maintenance 
of gonococcal infection (20,  23). 
Experimental urethral infection of male volunteers with 
well-characterized gonococcal strains provides  an opportu- 
nity to examine the role in infection of variable surface com- 
ponents such as Opa proteins, If expression  of one Opa pro- 
tein or a subset of them is required during early infection 
of the male urethra, then one would predict that the same 
Opa protein(s) would be expressed by organisms reisolated 
from different men infected with the same gonococcal strain. 
In a previous study by Swanson et al. (6),  three men were 
experimentally infected with an Opa-negative variant of strain 
MS11; reisolated gonococci were Opa positive, with the same 
Opa proteins expressed by the predominant reisolates from 
all three subjects. However, since the Opa protein repertoires 
of different strains may differ, it is difficult to generalize from 
results with one strain. We previously characterized the Opa 
proteins and genes encoding them in gonococcal strain FA1090 
(14, 25, 26). The opa genes of strains FA1090 and MS11 show 
little similarity in the HV regions (14, 15). In this study, 
we infected subjects with Opa-negative or Opa-positive vari- 
ants of strain FA1090 and characterized the Opa phenotypes 
of reisolated gonococci to determine if expression  of one or 
more of the Opa proteins of this strain is associated  with 
the ability of the organisms to establish  infection. 
Materials and Methods 
Bacterial Strain and Culture Conditions.  N. gonorrhoeae strain 
FA1090, which was isolated from a patient  with disseminated 
gonococcal  infection, has been described, as have  GC agar and broth 
culture media and conditions (8). 
Determination ofOpa Phenotype.  Strain  FA1090 has 11 opa loci 
encoding at least eight different Opa proteins (the opaB and opaF 
genes are duplicated) (14, 27). Expression of the Opa proteins is 
associated with differences in colony opacity when colonies are 
viewed with a dissecting microscope: Opa-negative, OpaB, and 
OpaE/K: transparent; OpaC and OpaF: slightly opaque; OpaA, 
OpaD, and Opal: deeply opaque. Opa expression was determined 
by colony blotting or Western blotting with mAbs specific  for Opa 
proteins of FA1090 (25, 26). mAb H.138 binds OpaA. mAb H.4 
binds OpaB and OpaD, which can be distinguished by a difference 
in electrophoretic  mobility on SDS-PAGE. mAb H.157 binds OpaC. 
In theory, this mAb should also bind the product of the opaJ locus 
(14), hut we have never detected expression of OpaJ and believe 
the opaJ gene is nonfunctional (our unpublished data), mAb H.164 
binds OpaE and OpaK, which can be distinguished  only by a slight 
difference  in electrophoretic  mobility. We did not analyze  all H.164- 
positive variants  by Western blotting; they are therefore  designated 
as OpaE/K, indicating that OpaE and/or OpaK is expressed, mAb 
H.156 binds to OpaF. Opal is not recognized by any of the afore- 
mentioned mAbs; its expression was identified by the character- 
istic colony morphology of Opal-expressing variants or by Western 
blotting with mAb 4B12, which recognizes most Opa proteins 
(27a). 
Colony immunoblots were performed  by a modification  of  a pre- 
viously described technique (26). Suspensions of individual colo- 
nies were spotted onto multiple nitrocellulose  membranes  (Schleicher 
& Schuell, Inc., Keene, NH) and probed with each of the Opa- 
specific mAbs. Bound antibody was detected with t~sI-Protein A 
(26) or with goat anti-mouse IgG conjugated to horseradish per- 
oxidase (Sigma Chemical Co., St. Louis, MO),  followed by en- 
hanced chemiluminescence substrate (ECL; Amersham Interna- 
tional, Amersham, UK). 
For Western blotting, bacteria harvested from agar plates and 
solubilized in loading buffer for 5 min at 100~  were run on 11% 
polyacrylamide  gels as described, except that SDS was not present 
in the gel (28). Separated proteins were transferred electrophoreti- 
cally to nitrocellulose  or PVDF membranes (Gelman Sciences, Ann 
Arbor,  MI)  and  probed with  mAbs (29), followed by  goat 
anti-mouse IgG horseradish peroxidase conjugate and ECL sub- 
strate, before autoradiography, mAb H.5 (specific  for protein I of 
FA1090) was included in each blot as a control and to provide a 
reference point for the migration of the different Opa proteins. 
To analyze Opa phenotype of colonies cultured from infected 
subjects, individual  colonies from the primary isolation plates were 
suspended in  microtiter  plate wells containing  freezer storage 
medium (FSM) (8). Aliquots of the suspensions were dotted onto 
nitrocellulose membranes, and binding of the Opa-specific mAbs 
was determined by immunoblotting.  The remaining suspensions 
were frozen at  -70~  If a colony suspension bound more than 
one mAh, the frozen stock was cultured and several colonies were 
tested by immunoblot and Western blotting to distinguish vari- 
ants expressing more than one Opa protein from those that were 
mixtures of multiple single Opa-expressing variants. 
Determination ofPilin Phenotype.  Elation of colony  variants was 
assessed by the characteristic colony morphology and competence 
for genetic transformation (30). For each variant used to inoculate 
volunteers, the DNA sequence of the pilin expression locus tilE) 
was determined as described (31). 
Determination of  Lipooligosaccharide  (LOS) Phenoty  F.  LOS pheno- 
type was determined by SDS-PAGE of proteinase K-treated cell 
lysates and Western blotting with LOS-specific  mAbs 3Fll, 1-1-M, 
and 6B4 as previously described (7, 32, 33). 
Preparation of the Bacterial Inoculum.  Pillared  colony  variants with 
defined  expression  of  LOS and Opa proteins were stored at - 70~ 
2 d before each trial, the desired frozen stock was subcultured to 
GC agar. 24 h later, individual colonies with appropriate colony 
opacity were suspended in FSM, dotted onto nitrocellulose filters, 
and tested by immunoblot with Opa-specific mAbs. Aliquots of 
each suspension were also inoculated onto fresh GC agar plates. 
After 22-24 h of incubation, plates inoculated with colonies that 
were confirmed to be of the correct Opa phenotype by immuno- 
blot were inspected  visually,  using a dissecting microscope  to iden- 
tify piliated colonies with the desired opacity for the inoculum sus- 
pension. Procedures for preparation of the suspension, filtering to 
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ganisms inoculated are described elsewhere (8). The Opa pheno- 
type of at least 100 colonies cultured from the final inoculum sus- 
pension was determined  by immunoblotting. 
Inoculation of Volunteers and Specimen Processing.  Procedures for 
recruiting  male subjects,  obtaining  informed  consent,  and  in- 
traurethal inoculation  of gonococci have been described (8). Sub- 
jects were treated with antibiotics when they developed signs of 
infection, or at the end of the 6-d trial.  Protocols were reviewed 
by the Institutional  Review Board and the General Clinical Re- 
search Center Advisory Board of the University of North Carolina 
at Chapel Hill. Subjects were compensated for their participation. 
Urine samples were collected 2 h after inoculation and at least daily 
thereafter; urethral swab samples were obtained when urethral dis- 
charge occurred. Specimens were processed and plated on culture 
media as described (8). 
Results 
Infection of Volunteers with Opa-negative Gonococci.  Gono- 
coccal strain FA1090 can express at least eight different Opa 
proteins (OpaA,  B, C,  D,  E, F, I,  and K), either  singly or 
in different combinations (Fig. 1) (14, 25, 26). To determine 
if particular Opa proteins of strain FA1090 were preferentially 
expressed during infection,  15 male volunteers were inocu- 
lated intraurethrally  with piliated, predominantly Opa-negative 
variants  of this  strain  in  five s.~parate trials.  The  inoculum 
size  varied  from  10  s  to  106  CFU,  with  the  percentage  of 
Opa-negative variants ranging from 79 to 99%. The remainder 
of the inoculum consisted of Opa-positive variants. Each in- 
oculum undoubtedly contained all of the different Opa-positive 
types, although  an Opa type that was present at <(0.8%  of 
the population would not have been detected, based on the 
number of inoculum colonies analyzed. Nine subjects became 
infected, seven of whom developed signs of acute urethritis 
before treatment.  Signs  of infection  developed from 33  to 
106 h  after inoculation.  Two subjects (volunteers  3 and 9) 
Figure  1.  The Opa protein repertoire of strain FA1090. Outer mem- 
brane proteins from variants expressing the different Opa proteins of this 
strain were subjected  to SDS-PAGE  and Coomassie  blue staining. The Opa 
protein expressed  by each variant is indicated above  the lane containing 
it. The two lanes  marked  E/K contain variants expressing  the two different 
proteins, OpaE and OpaK, that bind mAb H.164; we have  not determined 
formally which of the two is the product of the opaE or the opaK gene, 
and have therefore used the E/K designation for both. The arrows indi- 
cate the position of Protein I and of molecular mass standards. 
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had positive urine cultures but were treated before a urethral 
discharge  appeared. 
In all subjects, only a small percentage (0.003-0.02%)  of 
the number of organisms inoculated was recovered as viable 
CFU in urine samples obtained 2 h after inoculation. In sub- 
jects who subsequently developed signs of infection, the posi- 
tive 2-h culture was followed by a period of variable length 
during which few or no gonococci were recovered from urine 
cultures.  The  number  of gonococci  cultured  from  urine 
samples then increased by at least 10-fold; we have used the 
term "first positive culture" to describe samples obtained at 
this time,  which preceded the development  of signs  of in- 
fection. 
For each infected subject, gonococci cultured from urine 
or urethral swab samples were characterized for Opa protein 
expression.  This analysis  was done directly on 24-30-h-old 
colonies growing  on the primary isolation plates, without 
additional  in vitro passage, using mAbs specific for the FA1090 
Opa proteins in colony blotting and Western blotting proce- 
dures.  Table  1 shows the Opa phenotypes  of colonies cul- 
tured from the inoculum used in each trial,  and of colonies 
isolated from urine cultures.  For each subject, results are shown 
for the urine  culture  that  was done  2  h  after inoculation, 
for the first  subsequent  urine culture that  was positive for 
isolation of gonococci, and for the last urine culture before 
treatment.  Control experiments showed no difference in rel- 
ative survival when variants expressing each of the different 
Opa proteins were incubated in GC broth or in urine from 
uninfected  male  volunteers,  and  no  difference  in  plating 
efficiency  on  GC  agar. 
The distribution of Opa phenotypes in all of the 2-h urine 
culture samples was essentially the same as in the inoculum, 
with a predominance of Opa-negative colony variants.  How- 
ever, Opa proteins were expressed by the population of gono- 
cocci recovered from the first positive cultures and all subse- 
quent  cultures.  For six subjects (volunteers  1,  3,  8,  9,  13, 
and  16),  all of the colonies analyzed from the first positive 
culture expressed at least one Opa protein.  For each of these 
subjects, the gonococci isolated from the first positive cul- 
ture were quite homogenous in Opa protein expression, con- 
sisting  primarily  of one or two Opa types. Different  Opa 
variants predominated in different subjects, even in subjects 
who received the same inoculum: OpaF in volunteers 1 and 
8;  OpaB in volunteers 3,  9,  and  16; Opal in volunteer  13. 
In three subjects (2, 11, and 21), the first positive cultures 
yielded a mixture of Opa phenotypes, including Opa-negative 
variants  (15-57%).  Variants  expressing  OpaE/K,  OpaC, 
OpaF, or OpaB were represented at substantial proportions 
in these mixed populations.  Infection developed rapidly in 
these three subjects, with the first positive cultures obtained 
<(24 h  after inoculation.  In contrast,  infection took longer 
to develop (2-5 d until  the first positive culture)  in the six 
subjects who yielded a more homogeneous, uniformly Opa- 
positive population  of gonococcal variants. 
For five of the subjects who developed urethral discharge 
(volunteers  1, 2, 8,  13,  and 16), we analyzed colonies from 
cultures of urethral  discharge as well as urine.  Gram  stains 
of urethral discharge samples showed that both neutrophil- Table  1.  Opa Phenotypes of lnocula and Urine Isolates from Subjects Inoculated with Predominantly Opa-Negative Variants 
Opa phenotype  (% of colonies tested) 
Day of first 
culture/day of  First  positive 
Vol.  treatment  Inoculum  2-h culture  culture  Last culture 
1  2/4  Opa- (78)* 
E/K (8) 
F (6) 
A  (2) 
13 (2) 
c  (2) 
D  (2) 
B,E/K (1) 
A,D (1) 
2  1/3  Same 
3  3/4  Same 
8  3/5 
9  5/6 
Opa-  (89)* 
B  (7) 
E/K  (2) 
F (1) 




Opa- (85)  F (98)  F,I (60) 
E/K (6)  F (25) 
F (6)  F,C,I  (10) 
Opa- (78)  E/K (31)  F (57) 
F (9)  F (27)  B,F (11) 
E/K (6)  D  (15)  C  (6) 
Opa- (15)  E/K,F (6) 
B (5)  E/K,A  (6) 
F, I or C  (6) 
ND  B (69)  B (48)* 
D  (28)  B,I (45) 
ND  F (48)  F,B,E/K (64) 
B  (24)  r,I  (14) 
F,B (21)  F,B (11) 
F,B,E/K (7)  F,A,B,E/K (7) 
ND  B (88)  B (64) 
B,I (9)  B,I (23) 
associated and -free gonococci were present, but that gono- 
cocci were rarely associated with epithelial cells. The percen- 
tages of different Opa variants in these cultures were similar 
to those in the urine cultures obtained at the same time (data 
not  shown). 
For six subjects (1,  2,  3,  8,  16,  and 21),  the fraction of 
reisolated colonies expressing multiple Opa proteins increased 
over time. The Opa protein(s) that predominated in the popu- 
lation obtained from the first positive urine culture were gener- 
ally also expressed by the reisolates from later time points 
in infection, with simultaneous expression of additional pro- 
teins in those later samples (Table 1). Variants  expressing two 
or three Opa proteins were isolated frequently, and a few vari- 
ants expressing four or five Opa proteins simultaneously were 
recovered from cultures obtained late in the course of infec- 
tion. In addition to the time points presented in Table 1, we 
analyzed similar numbers of colonies from one to five inter- 
continued 
mediate time points for each subject, with  similar results. 
For three subjects (9, 11, and 13), there was little change in 
the proportion of the colonies expressing multiple Opa pro- 
teins during  the course of infection. 
The selection for Opa protein expression that occurred in 
vivo was not duplicated when variants were passaged in vitro. 
The Opa-negative inoculum variants were subjected to daily 
passage on GC  agar for 5 d,  incubation  for 5 d  on a GC 
agar plate before passage to a fresh plate, or growth in GC 
broth before plating on GC agar. No change in the percentage 
of Opa-negative colonies in the population occurred after these 
growth regimens (data not shown). When reisolates expressing 
three, four, or five Opa proteins were passaged on GC agar, 
they were difficult to maintain, rapidly switching off expres- 
sion of one or more of the proteins. 
A compilation of the number of colonies expressing each 
of the Opa proteins among the reisolates analyzed from all 
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Vol. 
Day of first 
culture/day of 
treatment  Inoculum 
Opa phenotype (%  of colonies tested) 
First positive 
2-h culture  culture  Last culture 
11  1/2  Same 
13  2/3  Opa-  (99) 
E/K (1) 
16  3/5  Same 




Opa- (100)  Opa- (57)  E/K (28) 
C (24)  Ova- (25) 
E/K (10)  C (23) 
F (10)  B (8) 
I  (6) 
Opa-(100)  I (62)  I (75) 
B,E/K (38)  I,C (6) 
I,E/K (6) 
D,E/K (6) 
Opa- (86)  B (70)  B (66)* 
B (11)  B,I (22)  B,E/K (13) 
I (9)  B,I  (9) 
I  (6) 
Opa- (90)  E/K (30)  s  E/K (58)s 
C  (7)  B (30)  E/K,B (28) 
Ova- (15)  E/K,F (8) 
B,I  (10)  E/K,I  (6) 
c  (lO) 
Opa phenotype  was determined for 120-140 colonies for each inoculum and for 20-103 colonies from each urine culture. Data are presented for 
the inocula  used in each trial, for colonies  cultured from a urine sample obtained  2 h after  inoculation,  for the colonies  from the first positive  culture, 
and for the last culture that was done before treatment. Subjects who received  the same inoculum  in a single trial are separated by single horizontal 
spaces; the double spaces separate independent  trials, in which different  inoculum  suspensions of Opa-negative variants were used. For the inocula, 
the Opa phenotypes  are presented for the entire  group of colonies analyzed;  for the colonies  cultured  from urine specimens, variants  that were detected 
at levels of 4% of the population or less are not listed. 
* Percentage of Opal variants in the inoculum was not determined. 
* 3% of colonies from the last culture for volunteers 3 and 16 were Opa negative. 
S OpaE/K variants isolated from this subject were analyzed  by Western blotting; all expressed the faster migrating species of this pair of proteins 
recognized by mAb H.164. 
nine subjects  (n  =  1717; samples including and subsequent 
to the first positive cultures) showed that variants expressing 
each of the eight Opa protein were recovered,  although the 
Opa types were not equally represented.  Variants expressing 
OpaB, Opal OpaE/K, and Opal were isolated most often 
(698,  649,  420,  and 408  colonies,  respectively),  whereas a 
smaller proportion expressed  OpaA, OpaD, or OpaC (29, 
85, and 68 colonies, respectively).  (In this analysis, colonies 
expressing multiple Opa proteins were tallied in the catego- 
ries corresponding to each of the proteins expressed,  so the 
sum of the numbers listed exceeds 1717.) OpaA was expressed 
only in combination with one or more other Opa proteins; 
the remaining proteins appeared  singly or in combination 
with other proteins with nearly equal frequency (data not 
shown). 
Infection of Volunteers with OpaF-expressing Gonococci.  The 
strong selection for Opa protein expression in vivo suggested 
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that inoculation with a variant expressing a suitable Opa pro- 
tein might facilitate infection when compared with an Opa- 
negative variant. We used a variant expressing Opal which 
was one of the Opa proteins expressed  most frequently by 
reisolates from the subjects inoculated with Opa-negative vari- 
ants. To minimize differences  other than Opa expression, 
OpaF-expressing  variant A36 was isolated directly from Opa- 
negative variant A21 in two in vitro passages. We examined 
expression  of two other variable  surface components, pilin 
and LOS, in the two variants.  The DNA sequence  of pilin 
expression locus (pilE) was the same at both, except for two 
single-base differences that would result in nonconservative 
amino acid substitutions at positions 54 and 56 of the pilin 
protein. Both variants produced the same three LOS species, 
one of which bound mAbs 3Fll and 6B4, which recognize 
LOS with a lacto-N-tetraose moiety. The second LOS spe- 
des bound mAb l-l-M, which recognizes a terminal N-acetyl- Table  2.  Comparison of the Infectivity of Opa-negative Variant A21 and OpaF Variant A36 
Inoculum 
No. infected/no.  Total no. 
Opa  challenged in  infected/no. 
CFU  phenotype*  separate trials  challenged 
106  Opa-  0/1  6/7 
2/2t 
4/4 
104  Opa-  0/1  1/3 
1/2 
106  OpaF  4/4  4/4 
104  OpaF  1/2'  1/2 
* The percentage  of the predominant Opa variant present in the inoculum  ranged from 83 to 90% for variant A36 and from 90 to 98% for variant A21. 
t These inocula were compared in a single trial. 
galactosamine moiety (33). The third species did not bind 
any of the three tested mAbs  (data not  shown). 
To compare infections caused by variants A36 and A21, 
we carried out trials with the two variants of inocula of 106 
and 104 CFU (Table 2). With an inoculum of 106 CFU, four 
of four subjects became infected with the OpaF variant; six 
of seven were infected with the Opa-negative variant. With 
104 CFU, one of two subjects developed infection after in- 
oculation of the OpaF variant; one of three became infected 
after inoculation of the Opa-negative variant. There was no 
difference in the length of time until the onset of signs  of 
infection in subjects infected with the two variants (mean 
of 38 h for the OpaF variant and 33 h for the Opa-negative 
variant). Thus, we detected no major difference in the viru- 
lence of variants A21  and A36 in this model of infection. 
We characterized the Opa phenotypes of reisolated colo- 
nies from urine cultures for three subjects who became in- 
fected after inoculation of 106 CFU  of OpaF variant A36 
Table  3.  Opa Phenotypes of the Inoculum and of Urine Isolates from Subjects Inoculated with a Predominantly OpaF-expressing Variant 
Opa phenotype 
Day of first 
culture/day of  First positive 
Vol.  treatment  Inoculum  2-h culture  culture  Last culture 
25  1/2  F  (90)  F  (90) 
Ova- (10)  Ova- (10) 




27  1/2  Same  F (80) 
Opa-(16) 
F,I (4) 
F,B  (51)  F (35)* 
F (32)  F,I (29) 
F,I (11)  F,B (26) 
F,B,A (6)  F,E (10) 
ND  F (93)* 
F,I (7) 
F (97)  F (86) 
F,C (3)  F,C (7) 
F,B (3) 
F,C,I (3) 
All three subjects were inoculated in a single trial, using the same inoculum suspension. Opa phenotype  was determined for 90 colonies cultured 
from the inoculum suspension and for 20-35 colonies from each urine culture. 
* The identification  of variants expressing multiple Opa proteins was based solely  on colony  immunoblot results on the primary reisolate colonies. 
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showed a similar distribution of Opa phenotypes to the in- 
oculum (90% OpaF, 10% Opa negative). All of the colonies 
obtained  from subsequent  cultures  expressed OpaF,  either 
singly or in combination with one or more additional Opa 
proteins. Colonies cultured from urethral discharge samples 
were similar to those from urine samples in Opa phenotype 
(data not shown). 
Discussion 
Appealing aspects of the human challenge model are that 
the natural human host is being studied and that the portal 
of entry is the same as in urogenital gonorrhea. Disadvan- 
tages of the model include the small numbers of subjects that 
can be studied, the inability to use invasive  procedures  to sample 
infected tissues, and the artificial nature of the inoculation 
procedure. In addition, the ethical necessity  to treat the subjects 
immediately upon development of signs or symptoms of in- 
fection means that this model is limited to early stages of 
infection. Nonetheless, previous studies of the expression of 
pill, LOS, and Opa proteins  during experimental infection 
have provided crucial insights into gonococcal virulence (5-7). 
In this study, our objective was to extend the previous work 
of Swanson et al. (6) on strain MSll by examining variation 
in Opa protein expression during experimental infection with 
Opa-negative  and Opa-positive  variants of strain FA1090. 
Opa-positive variants were abundant among gonococci iso- 
lated from subjects infected with Opa-negative  variants of 
strain FA1090. For six of the nine subjects, all of the colonies 
isolated from the first positive urine cultures expressed one 
or more Opa proteins. Even for the remaining three subjects, 
whose isolates showed more heterogeneity in Opa protein 
expression, the Opa-expressing  fraction of the gonococcal 
population (43-85%) from the first positive urine culture 
was increased substantially relative to that of the inoculum. 
We do not know if the emergence of Opa-expressing  or- 
ganisms reflects selection for a subpopulation of Opa-positive 
variants present in the inocula, or if induction of Opa-negative 
variants to produce Opa-expressing progeny occurred within 
the environment of the urethra. Phase variation of Opa pro- 
tein expression probably occurred during the course of infec- 
tion, based on the patterns of appearance  of  variants expressing 
multiple Opa proteins. However, it is not possible to deter- 
mine from our data if the rate of phase variation in vivo was 
the same as the rate that has been measured in vitro (11). 
The increase in the proportion of reisolates expressing mul- 
tiple Opa proteins as infection progressed in six of the sub- 
jects reinforces the conclusion that there is strong selection 
in vivo for expression of Opa proteins, particularly  since it 
was difficult to maintain the multiple expression state of the 
reisolates when they were passaged in vitro. We do not know 
what selective advantage is responsible for the preferential 
survival or proliferation of gonococci expressing multiple Opa 
proteins.  Perhaps it is not the specific identities  of the ex- 
pressed Opa proteins, but rather an increased amount of total 
Opa protein on the bacterial surface, resulting from several 
opa genes being expressed simultaneously, that is important 
to the success of the gonococcus. 
Relatively homogeneous populations of Opa variants, com- 
posed mostly of one or two types, emerged in most of the 
infected subjects. In contrast to our original prediction,  we 
did not isolate the same Opa variants from all of the infected 
subjects, even those subjects receiving the same inoculum. 
OpaB variants predominated in colonies cultured from three 
subjects, OpaF in two subjects and Opal and OpaE/K in 
one subject each. When the number of colonies expressing 
each Opa protein was totaled,  gonococci expressing OpaB, 
OpaF,  OpaE/K,  and Opal were isolated most frequently, 
whereas variants expressing OpaA, D, or C occurred rarely. 
The proteins expressed by the more abundant Opa variants 
may share some property that is important for establishing 
infection. However, we believe  that there are alternative factors 
contributing to their increased frequency of isolation. OpaB, 
E/K, and F variants were the Opa-positive variants present 
in the greatest numbers in the inocula, presumably because 
their relatively transparent  colony phenotype made it more 
difficult to screen them out in the final stages of inoculum 
preparation.  However, Opal variants, which have a deeply 
opaque colony phenotype, were also abundant among the 
reisolates, so the correlation between greater numbers in the 
inoculum and greater frequency of reisolation of Opa vari- 
ants was not complete. Another factor contributing to the 
disproportionate recovery  of  variants expressing  OpaB or OpaF 
was probably the duplication  of the opaB and opaF genes in 
the FA1090 chromosome, making it twice as likely that a 
gene encoding OpaB or OpaF would be expressing the pro- 
tein (14). Similarly, expression of either of two proteins con- 
tributed to the OpaE/K category. 
A model that is consistent with our results is that the success 
of one Opa-expressing  variant  over another in a given in- 
dividual is a random event. If most of the organisms inocu- 
lated into the urethra fail to survive, and if organisms ex- 
pressing at least one Opa protein are the ones most likely 
to persist (for unknown reasons), then the resulting popula- 
tion of gonococci would be derived from a few Opa-positive 
bacteria and would therefore be relatively homogeneous in 
Opa protein expression. The identity of the expressed Opa 
protein(s) would depend on which variants had a serendipi- 
tous survival of the initial clearance or killing mechanisms, 
and thus on the relative abundance of different Opa variants 
in the inoculum. The three subjects who developed infection 
most rapidly demonstrated the most heterogeneity in Opa 
expression of the reisolates, including Opa-negative variants. 
We hypothesize that a greater proportion of the inoculum 
survived in those subjects, so that it took less time for the 
proliferation of gonococci to reach the necessary level for a 
positive urine culture.  The resulting population would be 
derived from a larger number of progenitors and would there- 
fore be more heterogeneous. 
There are other possible explanations for the emergence 
of different Opa variants in different individuals. Genetically 
determined differences in host cell receptors might allow 
preferential adherence of one Opa variant  over another in 
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nizing Opa proteins could be responsible for selective killing 
of Opa variants. We found no evidence for Opa-specific IgG 
in preinfection sera (our unpublished data), although serum 
IgG levels may not reflect the potential for immunoselection 
at  the mucosal surface. 
We do not believe that changes during sample processing 
or in vitro growth contributed significantly  to the Opa pheno- 
types we detected. The similarity of Opa phenotypes in the 
inoculum and in colonies cultured from urine samples col- 
lected 2 h  after inoculation  argues  that  the procedures for 
inoculation and for culturing gonococci from urine samples 
did not cause artifactual shifts in Opa phenotypes. We ana- 
lyzed colonies  directly  from  the  primary  isolation  plates, 
without additional subculture. Also, we found no evidence 
for differential survival of Opa variants  in urine  or during 
growth on the different culture media,  and observed little 
or no shift in the Opa phenotypes of cultures grown under 
different conditions in vitro, including prolonged incubation 
of colonies. 
An additional procedural issue concerns whether organisms 
cultured from urine samples represent those that were actu- 
ally causing infection in the urethra.  Tightly adherent bac- 
teria or ones that have invaded epithelial cells might not be 
recovered from urine samples. We characterized bacteria cul- 
tured from urethral swab samples containing neutrophils and 
rare epithelial cells. The Opa profile of variants cultured from 
the swab samples was the same as those from urine samples 
taken at the same time. Preliminary immunofluorescence ex- 
periments  with  samples from two volunteers  showed that 
the Opa phenotype of neutrophil-associated gonococci in ure- 
thral discharge samples was the same as the predominant Opa 
phenotype of variants cultured from urine samples from those 
subjects (our unpublished  data). 
The results of our experiments with Opa-negative inocula 
of strain  FA1090 show both  similarities  to and differences 
from those obtained by Swanson et al. (6) with strain MS11. 
In both studies, there was strong selection for expression of 
one or more Opa proteins by the gonococci isolated from 
urine samples from infected volunteers. However, the same 
Opa proteins (OpaC and OpaA) predominated in reisolates 
from all three subjects infected with  strain  MS11,  whereas 
different Opa proteins (OpaB, F, I, or E/K) were expressed 
by reisolates from nine subjects infected with Opa-negative 
variants of strain FA1090. (In evaluating the results obtained 
with strains MS11 and FA1090, it is important to remember 
that Opa protein nomenclature is unrelated in the two strains, 
so that OpaA of MS11 is not the same protein as OpaA of 
FA1090.) These differences could be a consequence of strain 
differences between FA1090 and MS11,  although  the time 
course and features of experimental gonorrhea caused by the 
two strains are similar (5-7,  8).  Alternatively, our access to 
samples from a larger number of infected subjects may have 
revealed  variability in Opa expression that was also present 
but was not detected in the earlier study with strain MS11. 
The patterns of Opa expression in reisolates from subjects 
infected with strains MS11 or FA1090 show additional differ- 
ences when considered in light of recent in vitro studies. For 
strain MS11,  the OpaC and OpaA variants that were most 
abundant in reisolates from infected subjects have subsequently 
been shown to be associated with  attachment  to and inva- 
sion of epithelial cells,  and with lack of attachment  to neu- 
trophils (20-23).  The interactions  of some Opa variants of 
strain FA1090 with neutrophils have been characterized,  al- 
though  epithelial  cell invasion studies have not been done 
with this strain.  In contrast to the results obtained with strain 
MS11,  the OpaB and OpaF variants of strain FA1090 that 
were present in the greatest numbers in the reisolates from 
infected subjects expressed Opa proteins that are believed to 
promote association with neutrophils in vitro (34-36). It is 
difficult to resolve these apparent differences in the in vitro 
behavior of the Opa variants isolated from subjects experimen- 
tally infected with strains MS11 or FA1090.  Perhaps the at- 
tributes of Opa variants that have been assessed in in vitro 
cell culture  systems are  not in fact the ones that  are  most 
relevant in this model of in vivo infection. Further investiga- 
tions on the interactions  of Opa variants of strain  FA1090 
with neutrophils and other cell types may help to resolve this 
issue. 
There is an apparent  paradox in the results we obtained 
when  comparing  the  infectivity of the  Opa-negative  and 
OpaF-expressing variants.  Given the strong selection for Opa 
protein expression in vivo, we anticipated that an inoculum 
containing primarily Opa-positive variants would infect more 
men or be associated with more rapid development of infec- 
tion than an equivalent inoculum of an Opa-negative variant. 
However, there was no major difference in the ability of the 
OpaF-expressing and Opa-negative variants  to cause infec- 
tion,  in terms of either the number of subjects infected or 
the time until onset of signs of infection. We would prob- 
ably have not been able to detect subtle differences in infec- 
tivity of the two variants, due to the limited number of sub- 
jects available for this analysis. If expression of Opa proteins, 
including  OpaF,  is  advantageous  for  gonococci  of strain 
FA1090, then why was infection not more efficient with a 
preselected Opa-positive population? One possibility is that 
Opa protein expression is selected at an early stage of infec- 
tion but becomes essential only later in infection. Alterna- 
tively, there may be a threshold number of Opa-positive or- 
ganisms that is sufficient to establish infection.  At an inoculum 
of 104 CFU of Opa-negative variant A21, there were up to 
103 Opa-positive organisms inoculated. Perhaps  that number 
was sufficient to cause infection in some subjects. Rather than 
carry out additional  infection experiments  with  wild type 
gonococcal populations that will always contain mixtures of 
Opa variants, we believe that the best approach to resolving 
these questions is to construct mutants of strain FA1090 that 
are unable to express  some or all of the Opa proteins. Such 
mutants should make it possible to determine if the strong 
selection for Opa protein expression in vivo is a reflection 
of an essential role for the members of this protein family 
in the establishment or maintenance of gonococcal infection. 
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